Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Bishton · SciRah

Researcher profile · Semantic Scholar

M. Bishton

Share profile

M. Bishton — researcher profile on SciRah

h-index: 22
Works: 123
Citations: 1,234

Most-cited papers

Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity
T. Eyre, A. Kirkwood, Julia Wolf, C. Hildyard +13 more
2019British Journal of Haematology56 citations Open access
Semantic Scholar
Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013–2019
Hanhua Liu, C. Stiller, C. Crooks, B. Rous +14 more
2022British Journal of Haematology49 citations Open access
Semantic Scholar
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guideline.
Miriam F Cox, S. Mackenzie, R. Low, Michael Brown +17 more
2023The Lancet Rheumatology47 citations Open access
Semantic Scholar
Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience
A. Al-Hakim, J. Poulter, Dina Mahmoud, A. Rose +8 more
2022British Journal of Haematology47 citations Open access
Semantic Scholar
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients
R. McCulloch, D. Lewis, N. Crosbie, T. Eyre +21 more
2021British Journal of Haematology46 citations Open access
Semantic Scholar
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study
Michael L. Wang, R. Ramchandren, Robert W. Chen, Lionel Karlin +11 more
2021Journal of Hematology & Oncology46 citations Open access
Semantic Scholar
Impact of intended and relative dose intensity of R‐CHOP in a large, consecutive cohort of elderly diffuse large B‐cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age
T. Eyre, N. Martínez-Calle, C. Hildyard, D. Eyre +13 more
2019Journal of Internal Medicine46 citations
Semantic Scholar
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study.
A. Barraclough, M. Alzahrani, M. S. Ettrup, M. Bishton +16 more
2019Blood Advances46 citations Open access
Semantic Scholar
Mosunetuzumab in Combination with Lenalidomide Has a Manageable Safety Profile and Encouraging Activity in Patients with Relapsed/Refractory Follicular Lymphoma: Initial Results from a Phase Ib Study
F. Morschhauser, M. Bishton, T. Eyre, E. Bachy +13 more
2021Blood40 citations Open access
Semantic Scholar
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
E. González-Barca, A. Boumendil, D. Blaise, M. Trněný +25 more
2019Bone Marrow Transplantation39 citations Open access
Semantic Scholar
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
K. Lewis, L. Jakobsen, D. Villa, K. Smedby +9 more
2023Journal of Clinical Oncology36 citations Open access
Semantic Scholar
Incidence and survival of haemophagocytic lymphohistiocytosis: A population‐based cohort study from England
J. West, T. Card, M. Bishton, P. Lanyon +8 more
2021Journal of Internal Medicine36 citations Open access
Semantic Scholar
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline
T. Eyre, M. Bishton, R. McCulloch, M. O'Reilly +7 more
2023British Journal of Haematology31 citations Open access
Semantic Scholar
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP.
T. Eyre, W. Wilson, A. Kirkwood, Julia Wolf +14 more
2021Blood Advances29 citations Open access
Semantic Scholar
Temporal Trends in the Incidence of Hemophagocytic Lymphohistiocytosis: A Nationwide Cohort Study From England 2003–2018
J. West, Peter Stilwell, Hanhua Liu, L. Ban +7 more
2022medRxiv28 citations Open access
Semantic Scholar
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
D. Lewis, M. Jerkeman, L. Sorrell, David Wright +26 more
2025The Lancet25 citations Open access
Semantic Scholar
Ibrutinib-Rituximab Is Superior to Rituximab-Chemotherapy in Previously Untreated Older Mantle Cell Lymphoma Patients: Results from the International Randomised Controlled Trial, Enrich
D. Lewis, M. Jerkeman, L. Sorrell, David Wright +27 more
2024Blood24 citations
Semantic Scholar
The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma
A. Barraclough, M. Bishton, Che-Ah Y. Chan, D. Villa +1 more
2021British Journal of Haematology24 citations Open access
Semantic Scholar
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing
Suzanne O. Arulogun, D. Brian, H. Goradia, A. Cooney +22 more
2023American journal of hematology/oncology22 citations Open access
Semantic Scholar
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
A. Tivey, R. Shotton, T. Eyre, D. Lewis +64 more
2023Blood Advances21 citations Open access
Semantic Scholar
Preliminary Findings of a Phase Ib/II Trial Indicate Manageable Safety and Promising Efficacy for Mosunetuzumab in Combination with Lenalidomide (M+Len) in Previously Untreated (1L) Follicular Lymphoma (FL)
F. Morschhauser, K. Patel, S. Bobillo, R. Córdoba +16 more
2023Blood17 citations Open access
Semantic Scholar
High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients
K. Lewis, L. Jakobsen, D. Villa, S. Bobillo +46 more
2021Blood17 citations Open access
Semantic Scholar
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis
Alexandros Rampotas, M. Wilson, O. Lomas, N. Denny +25 more
2021British Journal of Haematology17 citations Open access
Semantic Scholar
Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP
T. Eyre, N. Martínez-Calle, C. Hildyard, D. Eyre +12 more
2019British Journal of Haematology15 citations Open access
Semantic Scholar
Frontline management of nodular lymphocyte predominant Hodgkin lymphoma – a retrospective UK multicentre study
M. Wilson, T. Bagguley, Alexandra G. Smith, E. Roman +6 more
2019British Journal of Haematology13 citations Open access
Semantic Scholar
Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020
Hanhua Liu, S. Stanworth, S. McPhail, M. Bishton +3 more
2024Blood Advances12 citations Open access
Semantic Scholar
1-year survival in haemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003–2018
J. West, Peter Stilwell, Hanhua Liu, L. Ban +7 more
2023Journal of Hematology & Oncology12 citations Open access
Semantic Scholar
CELESTIMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab plus lenalidomide versus rituximab plus lenalidomide in patients with relapsed or refractory follicular lymphoma who have received ≥ 1 line of systemic therapy.
L. Nastoupil, F. Morschhauser, C. Scholz, M. Bishton +9 more
2022Journal of Clinical Oncology12 citations
Semantic Scholar
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance
A. Barraclough, J. England, D. Villa, J. Wight +26 more
2023Haematologica11 citations Open access
Semantic Scholar
Improved survival outcomes despite older age at diagnosis: an era‐by‐era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom
F. Kaji, N. Martínez-Calle, M. Bishton, R. Figueroa +11 more
2021British Journal of Haematology11 citations Open access
Semantic Scholar
A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population‐based health data
M. Bishton, Peter Stilwell, T. Card, P. Lanyon +15 more
2021medRxiv10 citations Open access
Semantic Scholar
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience
R. Shotton, R. Broadbent, A. Alchawaf, M. Mohamed +22 more
2023Blood Advances9 citations Open access
Semantic Scholar
Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom
A. Minson, N. Hamad, Pietro R. Di Ciaccio, D. Talaulikar +15 more
2023British Journal of Haematology7 citations Open access
Semantic Scholar
Ibrutinib Plus Venetoclax in Patients With Relapsed/Refractory Mantle Cell Lymphoma: Results From the Safety Run-In Period of the Phase 3 Sympatico Study
C. Tam, R. Ramchandren, Robert Chen, Lionel Karlin +12 more
2020Blood7 citations
Semantic Scholar
Extended follow‐up of CD4+ T cell recovery kinetics in a large cohort of patients with B‐cell lymphoproliferative disease treated with rituximab‐bendamustine
R. Gaiolla, S. Hartley, A. Beech, Helen Knight +4 more
2020Hematological Oncology7 citations Open access
Semantic Scholar
Efficacy and Safety of Single-Agent Zandelisib Administered By Intermittent Dosing in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Final Results of the Tidal Phase 2 Study
A. Zelenetz, W. Jurczak, V. Ribrag, K. Linton +14 more
2022Blood6 citations Open access
Semantic Scholar
Population‐based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large‐cell lymphoma using Public Health England data
S. Halligan, M. Grainge, N. Martínez-Calle, C. Fox +1 more
2021British Journal of Haematology6 citations Open access
Semantic Scholar
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival
M. Bishton, S. Rule, W. Wilson, D. Turner +5 more
2020British Journal of Haematology6 citations Open access
Semantic Scholar
Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study.
L. Gumber, R. Omidvar, F. Gonnelli, Adam M. Taylor +8 more
2025The Lancet Rheumatology5 citations Open access
Semantic Scholar
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
A. Zelenetz, W. Jurczak, V. Ribrag, K. Linton +15 more
2024HemaSphere5 citations Open access
Semantic Scholar
1- and 5-Year Survival for Adults with Acute Myeloid Leukaemia and 30-Day Mortality after Initial Systemic Anti-Cancer Therapy, with an Exploration of Factors Associated with Poorer Outcomes: Data from a National Registry in England, 2013-2020
Hanhua Liu, S. Stanworth, Sean McMphail, M. Bishton +3 more
2023Blood5 citations Open access
Semantic Scholar
Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma
M. Sorigué, M. Bishton, E. Domingo-Domènech, A. McMillan +9 more
2019Leukemia and Lymphoma5 citations Open access
Semantic Scholar
Ibrutinib at First Relapse for Mantle Cell Lymphoma: A United Kingdom Real World Analysis of Outcomes in 169 Patients
R. McCulloch, S. Rule, T. Eyre, H. Goradia +29 more
2019Blood5 citations Open access
Semantic Scholar
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial
G. McIlroy, Siân Lax, C. Gaskell, Aimee Jackson +11 more
2024BMC Cancer4 citations Open access
Semantic Scholar
Incidence and survival in patients with Enteropathy Associated T-cell lymphoma: nationwide registry studies from England and Denmark.
J. West, P. Jepsen, T. Card, C. Crooks +1 more
2023Gastroenterology4 citations Open access
Semantic Scholar
P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA
L. Nastoupil, F. Morschhauser, C. Scholz, M. Bishton +9 more
2022HemaSphere4 citations Open access
Semantic Scholar
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort
N. Martínez-Calle, A. Kirkwood, M. Lamb, Alex Smith +16 more
2021Advances in Therapy4 citations Open access
Semantic Scholar
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant‐eligible patients with previously untreated mantle cell lymphoma
Z. Ng, M. Bishton, D. Ritchie, R. Campbell +22 more
2019Hematological Oncology4 citations Open access
Semantic Scholar
RESULTS FROM THE SAFETY RUN‐IN PERIOD OF THE SYMPATICO STUDY EVALUATING IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
Michael L. Wang, Rod Ramchandren, Robert W. Chen, Lionel Karlin +14 more
2019Hematological Oncology4 citations
Semantic Scholar
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis
M. Wilson, K. Lewis, A. Kirkwood, K. Cwynarski +35 more
2026Journal of Clinical Oncology3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Eyre×17
Invite
T. Eyre — researcher profile on SciRah
N. Martínez-Calle×10
Invite
N. Martínez-Calle — researcher profile on SciRah
C. Fox×10
Invite
C. Fox — researcher profile on SciRah
K. Linton×8
Invite
K. Linton — researcher profile on SciRah

×7

Invite

G. Collins — researcher profile on SciRah

Invite

C. Crooks — researcher profile on SciRah

Invite

T. Card — researcher profile on SciRah

Invite

J. West — researcher profile on SciRah

Invite

E. Hawkes — researcher profile on SciRah

Invite

C. Hildyard — researcher profile on SciRah

Invite

A. McMillan — researcher profile on SciRah

Invite

M. Bythell — researcher profile on SciRah